A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their ...

Philadelphia's leading health systems will no longer consider race in four common screening tools for lung, kidney, and ...

October 23, 2024, 02:02 am ET, BY Rolland S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Check the time ...

NeoGenomics has secured conditional approval from the New York State Department of Health (NYSDOH) for two of its ...

Lung Clear Pro is a dietary supplement to resolve respiratory issues If you are considering it here is everything you should ...

NeoGenomics has received conditional approval from the NYSDOH for its Neo Comprehensive Solid Tumor assay and NeoTYPE DNA & ...

The screenings are being held Wednesday evenings through the end of 2025 as well as on Lung Cancer Screening Day Nov. 9.

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

UK-based Cizzle Biotechnology signed the licensing agreement with its US-based partner, Cizzle Bio, for the commercialization of early cancer detection tests.

Cizzle Biotechnology Holdings plc (Cizzle), the UK based diagnostics developer, is pleased to announce that it has signed an exclusive licensing agreement with Cizzle Bio granting exclusive rights to ...